Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q86SQ4: Variant p.Val741Glu

Adhesion G-protein coupled receptor G6
Gene: ADGRG6
Feedback?
Variant information Variant position: help 741 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Valine (V) to Glutamate (E) at position 741 (V741E, p.Val741Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (V) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In LCCS9; decreases the autoprocessing/cleavage of the receptor. Any additional useful information about the variant.


Sequence information Variant position: help 741 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1221 The length of the canonical sequence.
Location on the sequence: help ASVILPPNLLENLSPEDSVL V RRAQFTFFNKTGLFQDVGPQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         ASVILPPNLLENLSPEDSVLVRRAQFTFFNKTGLFQDVGPQ

Mouse                         ASVILPPNLLENLSPEDSVLVRRAQFTFFNKTGLFQDVGSQ

Zebrafish                     AVVTLPPTLLQNLSLSQIEKVSRINFMFFGRTGLFQDHQNN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 38 – 1221 Adhesion G-protein coupled receptor G6
Chain 38 – 840 ADGRG6 N-terminal fragment
Topological domain 38 – 862 Extracellular
Domain 670 – 853 GAIN-B
Region 41 – 852 Inhibits receptor signaling in absence of type IV collagen
Region 473 – 837 Mediates interaction with laminin-2
Glycosylation 750 – 750 N-linked (GlcNAc...) asparagine



Literature citations
Mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita.
Ravenscroft G.; Nolent F.; Rajagopalan S.; Meireles A.M.; Paavola K.J.; Gaillard D.; Alanio E.; Buckland M.; Arbuckle S.; Krivanek M.; Maluenda J.; Pannell S.; Gooding R.; Ong R.W.; Allcock R.J.; Carvalho E.D.; Carvalho M.D.; Kok F.; Talbot W.S.; Melki J.; Laing N.G.;
Am. J. Hum. Genet. 96:955-961(2015)
Cited for: FUNCTION; INVOLVEMENT IN LCCS9; VARIANTS LCCS9 GLU-741 AND GLU-769; CHARACTERIZATION OF VARIANT LCCS9 GLU-741;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.